Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Detecting causal interdependence in simulated neural signals based on pairwise and multivariate analysis.

Yang C, Le Bouquin Jeannes R, Faucon G, Wendling F.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:162-5. doi: 10.1109/IEMBS.2010.5627241.

2.

A physiologically based model for temporal envelope encoding in human primary auditory cortex.

Dugué P, Le Bouquin-Jeannès R, Edeline JM, Faucon G.

Hear Res. 2010 Sep 1;268(1-2):133-44. doi: 10.1016/j.heares.2010.05.014. Epub 2010 Jun 1.

PMID:
20685388
3.

Multivariate predictive model for dyslexia diagnosis.

Le Jan G, Le Bouquin-Jeannès R, Costet N, Trolès N, Scalart P, Pichancourt D, Faucon G, Gombert JE.

Ann Dyslexia. 2011 Jun;61(1):1-20. doi: 10.1007/s11881-010-0038-5. Epub 2010 Aug 3.

PMID:
20680527
4.

Temporal envelope processing in the human auditory cortex: response and interconnections of auditory cortical areas.

Gourévitch B, Le Bouquin Jeannès R, Faucon G, Liégeois-Chauvel C.

Hear Res. 2008 Mar;237(1-2):1-18. doi: 10.1016/j.heares.2007.12.003. Epub 2007 Dec 28.

PMID:
18255243
5.

Discriminatory validity of dyslexia screening tasks in French school age children.

Le Jan G, Le Bouquin Jeannès R, Costet N, Faucon G.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:3781-5.

6.

Improving the dynamics of responses to amplitude modulated stimuli by modeling inhibitory interneurons in cochlear nucleus.

Dugué P, Le Bouquin Jeannès R, Faucon G.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:1286-9.

7.

Short-term effects of GSM mobiles phones on spectral components of the human electroencephalogram.

Maby E, Le Bouquin Jeannes R, Faucon G.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:3751-4.

PMID:
17946579
8.

[Epidemiology of Haemophilus influenzae strains collected in 2004 in France and in vitro assessment of their susceptibility to antibiotics].

Dabernat H, Seguy M, Faucon G, Delmas C.

Med Mal Infect. 2007 Jun;37(6):320-4. Epub 2007 May 29. French.

PMID:
17532588
9.

Linear and nonlinear causality between signals: methods, examples and neurophysiological applications.

Gourévitch B, Bouquin-Jeannès RL, Faucon G.

Biol Cybern. 2006 Oct;95(4):349-69. Epub 2006 Aug 23. Review.

PMID:
16927098
10.

Scalp localization of human auditory cortical activity modified by GSM electromagnetic fields.

Maby E, Jeannes Rle B, Faucon G.

Int J Radiat Biol. 2006 Jul;82(7):465-72.

PMID:
16882618
11.

Evidence of functional connectivity between auditory cortical areas revealed by amplitude modulation sound processing.

Guéguin M, Le Bouquin-Jeannès R, Faucon G, Chauvel P, Liégeois-Chauvel C.

Cereb Cortex. 2007 Feb;17(2):304-13. Epub 2006 Mar 2.

12.

Evaluation of two computational models of amplitude modulation coding in the inferior colliculus.

Guérin A, Jeannès Rle B, Bès J, Faucon G, Lorenzi C.

Hear Res. 2006 Jan;211(1-2):54-62. Epub 2005 Nov 11.

PMID:
16289669
13.

Genotyping of type b Haemophilus influenzae strains, comparison of strains collected before and during vaccine availability.

Dabernat H, Pélissier R, Faucon G, Séguy M, Delmas C.

Med Mal Infect. 2005 Apr;35(4):205-12.

PMID:
15914289
14.

Effects of GSM signals on auditory evoked responses.

Maby E, Le Bouquin Jeannès R, Faucon G, Liégeois-Chauvel C, De Sèze R.

Bioelectromagnetics. 2005 Jul;26(5):341-50.

PMID:
15887252
15.

[Epidemiology of Haemophilus influenzae strains identified in 2001 in France, and assessment of their susceptibility to beta-lactams].

Dabernat H, Seguy M, Faucon G, Delmas C.

Med Mal Infect. 2004 Feb;34(2):97-101. French.

PMID:
15620022
16.

Analysis of auditory evoked potential parameters in the presence of radiofrequency fields using a support vector machines method.

Maby E, Le Bouquin Jeannès R, Liégeois-Chauvel C, Gourevitch B, Faucon G.

Med Biol Eng Comput. 2004 Jul;42(4):562-8.

PMID:
15320468
17.

Haemophilus influenzae carriage in children attending French day care centers: a molecular epidemiological study.

Dabernat H, Plisson-Sauné MA, Delmas C, Séguy M, Faucon G, Pélissier R, Carsenti H, Pradier C, Roussel-Delvallez M, Leroy J, Dupont MJ, De Bels F, Dellamonica P.

J Clin Microbiol. 2003 Apr;41(4):1664-72.

18.

Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae.

Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, Pasquier C.

Antimicrob Agents Chemother. 2002 Jul;46(7):2208-18.

19.
20.

Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.

Bui-Xuan B, Aupetit JF, Freysz M, Faucon G, Timour Q.

Pharmacotherapy. 1997 Jul-Aug;17(4):737-45.

PMID:
9250551
21.

Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.

Aupetit JF, Freysz M, Faucon G, Loufoua-Moundanga J, Coquelin H, Timour Q.

Acta Anaesthesiol Scand. 1997 Apr;41(4):516-23.

PMID:
9150782
22.

Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.

Timour Q, Bui-Xuan B, Aupetit JF, Freysz M, Evreux JC, Faucon G.

Jpn Heart J. 1997 Mar;38(2):237-51.

PMID:
9201111
23.

Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.

Aupetit JF, Loufoua-Moundanga J, Faucon G, Timour Q.

Br J Pharmacol. 1997 Feb;120(3):523-9.

24.

Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.

Timour Q, Aupetit JF, Freysz M, Frassati D, Faucon G.

Can J Physiol Pharmacol. 1996 Dec;74(12):1308-14.

PMID:
9047040
25.

Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions.

Bui-Xuan B, Aupetit JF, Freysz M, Loufoua J, Faucon G, Timour Q.

Cardiovasc Res. 1996 Dec;32(6):1056-63.

PMID:
9035900
26.

Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.

Timour Q, Bui-Xuan B, Faucon G, Aupetit JF.

Cardiovasc Drugs Ther. 1996 Sep;10(4):447-54.

PMID:
8924058
27.

Change of a beneficial effect into an untoward effect by ischaemia: effect of quinidine-like drugs on vulnerability to ventricular fibrillation.

Aupetit JF, Freysz M, Faucon G, Loufoua J, Timour Q.

Environ Toxicol Pharmacol. 1996 Aug 15;2(1):1-7.

PMID:
21781694
28.

Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.

Bui-Xuan B, Aupetit JF, Freysz M, Loufoua-Moundanga J, Faucon G, Timour Q.

Arch Int Pharmacodyn Ther. 1996 May-Jun;331(3):246-62.

PMID:
9124997
29.

[Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].

Timour Q, Freysz M, Aupetit JF, Loufoua J, Frassati D, Faucon G.

Bull Acad Natl Med. 1996 Jan;180(1):215-26; discussion 226-7. French.

PMID:
8696877
30.

Cardiac implications of amlodipine-dantrolene combinations.

Freysz M, Timour Q, Bernaud C, Bertrix L, Faucon G.

Can J Anaesth. 1996 Jan;43(1):50-5.

PMID:
8665636
31.

Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart.

Ovize M, Aupetit JF, Rioufol G, Loufoua J, André-Fouët X, Minaire Y, Faucon G.

Am J Physiol. 1995 Jul;269(1 Pt 2):H72-9.

PMID:
7631877
32.

Molecular analysis by pulsed-field gel electrophoresis of penicillin-resistant Streptococcus pneumoniae from Toulouse, France.

Lefèvre JC, Bertrand MA, Faucon G.

Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):491-7.

PMID:
7588821
33.

Profibrillatory effects of lidocaine in the acutely ischemic porcine heart.

Aupetit JF, Timour Q, Loufoua-Moundanga J, Barral-Cadière L, Lopez M, Freysz M, Faucon G.

J Cardiovasc Pharmacol. 1995 May;25(5):810-6.

PMID:
7630159
34.

Bupivacaine hastens the ischemia-induced decrease of the electrical ventricular fibrillation threshold.

Freysz M, Timour Q, Bertrix L, Loufoua J, Aupetit JF, Faucon G.

Anesth Analg. 1995 Apr;80(4):657-63.

PMID:
7893014
35.

Time course of electrical fibrillation threshold during brief periods of myocardial ischemia and the genesis of fibrillation: role of calcium.

Timour Q, Aupetit JF, Chevrel G, Loufoua-Moundanga J, Omar S, Faucon G.

Cardiovasc Drugs Ther. 1994 Dec;8(6):877-9. No abstract available.

PMID:
7742268
36.

[Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia].

Timour Q, Aupetit JF, Loufoua-Moundanga JL, Barral-Cadière L, Freysz M, Faucon G.

Therapie. 1994 Jul-Aug;49(4):349-53. French.

PMID:
7878603
37.

Pulsed field gel electrophoresis for molecular epidemiology of penicillin resistant Streptococcus pneumoniae strains.

Lefèvre JC, Gasc AM, Lemozy J, Sicard AM, Faucon G.

Pathol Biol (Paris). 1994 May;42(5):547-52.

PMID:
7824331
38.

Vulnerability to ventricular fibrillation related to ischaemia: comparison of the acute effects of beta-blockers and calcium antagonists.

Aupetit JF, Timour Q, Freysz M, Loufoua-Moundanga J, Omar S, Chevrel G, Faucon G.

Arch Int Pharmacodyn Ther. 1994 Jan-Feb;327(1):25-39.

PMID:
7944825
39.

Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem.

Aupetit JF, Timour Q, Chevrel G, Loufoua-Moundanga J, Omar S, Faucon G.

Naunyn Schmiedebergs Arch Pharmacol. 1993 Nov;348(5):509-14.

PMID:
8114951
40.

DNA fingerprinting of Streptococcus pneumoniae strains by pulsed-field gel electrophoresis.

Lefevre JC, Faucon G, Sicard AM, Gasc AM.

J Clin Microbiol. 1993 Oct;31(10):2724-8.

41.

[Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation].

Aupetit JF, Timour Q, Chevrel G, Omar S, Loufoua-Moundanga J, Faucon G.

Therapie. 1993 Jul-Aug;48(4):403-7. French.

PMID:
8128424
42.

Enhancement by ischemia of the risk of cardiac disorders, especially fibrillation, in regional anesthesia with bupivacaine.

Freysz M, Timour Q, Bertrix L, Loufoua-Moundanga J, Omar S, Faucon G.

Acta Anaesthesiol Scand. 1993 May;37(4):350-6.

PMID:
8322562
43.

Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.

Aupetit JF, Timour Q, Larbre JP, Loufoua-Moundanga J, Kioueh I, Lopez M, Faucon G.

Cardiovasc Drugs Ther. 1993 Apr;7(2):217-23.

PMID:
8357775
44.

Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.

Timour Q, Aupetit JF, Loufoua-Moundanga J, Kioueh I, Omar S, Chevrel G, Faucon G.

Fundam Clin Pharmacol. 1992;6(4-5):159-67.

PMID:
1427561
45.

Pharmacokinetics of cyclosporine in hyperlipidaemic long-term survivors of heart transplantation. Lack of interaction with the lipid-lowering agent, fenofibrate.

deLorgeril M, Boissonnat P, Bizollon CA, Guidollet J, Faucon G, Guichard JP, Levy-Prades-Sauron R, Renaud S, Dureau G.

Eur J Clin Pharmacol. 1992;43(2):161-5.

PMID:
1425874
46.

Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.

Timour Q, Larbre JP, Kioueh I, Aupetit JF, Loufoua-Moundanga J, Vialle A, Faucon G.

Arch Int Pharmacodyn Ther. 1992 Jan-Feb;315:30-46.

PMID:
1384452
47.

Is the antianginal action of trimetazidine independent of hemodynamic changes?

Timour Q, Harpey C, Durr F, Faucon G.

Cardiovasc Drugs Ther. 1991 Dec;5(6):1043-4. No abstract available.

PMID:
1801891
48.

Adverse interaction between bupivacaine and halothane on ventricular contractile force and intraventricular conduction in the dog.

Bertrix L, Timour Q, Mazze RI, Freysz M, Samii K, Faucon G.

Anesth Analg. 1991 Oct;73(4):434-40.

PMID:
1897769
49.

Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.

Timour Q, Aupetit JF, Loufoua-Moundanga J, Gerentes-Chassagne I, Kioueh I, Faucon G.

Naunyn Schmiedebergs Arch Pharmacol. 1991 Jun;343(6):645-51.

PMID:
1944606
50.

[Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].

Faucon G, Aupetit JF, Gerentes-Chassagne I, Loufoua-Moundanga J, Larbre JP, Timour Q.

Bull Acad Natl Med. 1991 Feb;175(2):217-24; discussion 224-5. French.

PMID:
1907520

Supplemental Content

Loading ...
Support Center